NFKB1 and breast cancer: The mechanisms through which resistin can promote the EMT are not fully elucidated, but different studies have suggested that resistin, via its interaction with TLR4, can trigger NF-kB/STAT3 signalling, which results in the upregulation of EMT-related transcription factors and consequently BC promotion [140].